Atlas Trials

Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

Clinical trial NCT03266458 · UNKNOWN

Trial details

NCT number
NCT03266458
Sponsor
Assiut University
Status
UNKNOWN
Study type
OBSERVATIONAL
Contrast-induced Nephropathy
Start date
2018-01-01
Primary completion
2018-11-30
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.